Skip to search.
 STI Down 0.09%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
2.41 Down 0.19(7.31%) 10 Dec 05:00 SGT
Prev Close:2.60
Open:2.60
Bid:2.36 x 500
Ask:2.75 x 1000
1y Target Est:7.67
Beta:2.38641
Earnings Date:8 Mar - 13 Mar (Est.)
Day's Range:2.32 - 2.66
52wk Range:0.16 - 4.75
Volume:515,136
Avg Vol (3m):2,618,670
Market Cap:25.85M
P/E (ttm):N/A
EPS (ttm):-4.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GALEDown 7.31%25.85M
CELGUp 0.36%87.96B
VSTMUp 3.45%44.39M
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.64
Quarterly EPS Est (Dec-16) :-0.77
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback